These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37500577)

  • 1. Treatment Outcomes of Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Effects of the Electrode Type and Placement Method.
    Park J; Lee MW; Ahn SH; Han S; Min JH; Cha DI; Song KD; Kang TW; Rhim H
    Korean J Radiol; 2023 Aug; 24(8):761-771. PubMed ID: 37500577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments.
    Hong SJ; Kim JH; Yoon JH; Park JH; Yoon JH; Kim YJ; Yu SJ; Cho EJ; Lee JM
    Korean J Radiol; 2024 May; 25(5):438-448. PubMed ID: 38685734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No-Touch vs. Conventional Radiofrequency Ablation Using Twin Internally Cooled Wet Electrodes for Small Hepatocellular Carcinomas: A Randomized Prospective Comparative Study.
    Suh YS; Choi JW; Yoon JH; Lee DH; Kim YJ; Lee JH; Yu SJ; Cho EJ; Yoon JH; Lee JM
    Korean J Radiol; 2021 Dec; 22(12):1974-1984. PubMed ID: 34668352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ablation performance between dual internally cooled wet tip and conventional dual internally cooled tip radiofrequency electrodes: an experimental study in
    Cha DI; Lee MW; Jeong WK; Ha SY; Ahn SH; Rhim H; Lim HK
    Int J Hyperthermia; 2021; 38(1):332-340. PubMed ID: 33627017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis.
    Kim TH; Lee JM; Lee DH; Joo I; Park SJ; Yoon JH
    Eur Radiol; 2023 Jan; 33(1):545-554. PubMed ID: 35907024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Lee DH; Lee MW; Kim PN; Lee YJ; Park HS; Lee JM
    Radiology; 2021 Oct; 301(1):229-236. PubMed ID: 34313474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of hepatocellular carcinoma.
    Kim JH; Kim PN; Won HJ; Shin YM
    AJR Am J Roentgenol; 2012 Feb; 198(2):471-6. PubMed ID: 22268196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching Monopolar Radiofrequency Ablation Using a Separable Cluster Electrode in Patients with Hepatocellular Carcinoma: A Prospective Study.
    Choi JW; Lee JM; Lee DH; Yoon JH; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    PLoS One; 2016; 11(8):e0161980. PubMed ID: 27575787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of therapeutic efficacy and safety of radiofrequency ablation of hepatocellular carcinomas between internally cooled 15-G and 17-G single electrodes.
    Park HJ; Lee MW; Song KD; Cha DI; Rhim H; Kang TW; Lim S; Lim HK
    Br J Radiol; 2014 Apr; 87(1036):20130534. PubMed ID: 24646182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No-Touch Radiofrequency Ablation for Early Hepatocellular Carcinoma: 2023 Korean Society of Image-Guided Tumor Ablation Guidelines.
    Han S; Lee MW; Lee YJ; Hong HP; Lee DH; Lee JM
    Korean J Radiol; 2023 Aug; 24(8):719-728. PubMed ID: 37500573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Local Tumor Progression in Perivascular Hepatocellular Carcinoma by Combination Therapy with Radiofrequency Ablation and Percutaneous Ethanol Injection: A Propensity Score Matching Analysis.
    Takata K; Tanaka T; Anan A; Fukunaga A; Nagata T; Fukuda H; Yamauchi R; Kunimoto H; Yokoyama K; Morihara D; Takeyama Y; Iwata K; Shakado S; Sakisaka S; Hirai F
    Oncology; 2022; 100(6):303-312. PubMed ID: 35114665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
    Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
    Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
    Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
    Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy.
    Kim SW; Rhim H; Park M; Kim H; Kim YS; Choi D; Lim HK
    Korean J Radiol; 2009; 10(4):366-76. PubMed ID: 19568465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation using internally cooled wet electrodes in bipolar mode for the treatment of recurrent hepatocellular carcinoma after locoregional treatment: A randomized prospective comparative study.
    Choi JW; Lee JM; Lee DH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Cho EJ
    PLoS One; 2020; 15(9):e0239733. PubMed ID: 32986758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of subcapsular versus nonsubcapsular hepatocellular carcinomas ≤ 3 cm: analysis of long-term outcomes from two large-volume liver centers.
    Han K; Kim JH; Kim GH; Kim JH; Kim SY; Park SH; Moon S; Kwon JH; Kim GM; Lee SJ; Won HJ; Shin YM
    Eur Radiol; 2024 Mar; 34(3):1578-1586. PubMed ID: 37646813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
    Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression.
    Cao S; Zou Y; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J
    Int J Hyperthermia; 2022; 39(1):1-7. PubMed ID: 34937501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.